CSBR - Champions Oncology, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD

Champions Oncology, Inc.

One University Plaza
Suite 307
Hackensack, NJ 07601
United States
201-808-8400
http://www.championsoncology.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees115

Key Executives

NameTitlePayExercisedYear Born
Dr. Ronnie MorrisCEO & Director146.28kN/A1966
Mr. David Barry Miller M.B.A.Chief Financial Officer250kN/A1969
Dr. Philip P. BreitfeldChief Strategy & Innovation Officer and DirectorN/AN/A1953
Mr. Mark WeinsteinChief Information OfficerN/AN/AN/A
Mr. Bruce RuggeriChief Scientific OfficerN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assist physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. It also offers POS products, including personalized tumor boards that are designed to provide access to oncologists with expertise in particular tumor types; and provides access to gene sequencing that analyzes the genetic makeup of patient's tumor for the purpose of identifying potentially useful drugs. In addition, the company offers Translational Oncology Solutions, including a preclinical Tumorgraft Technology Platform to pharmaceutical and biotechnology companies. It markets its products through Internet, word of mouth, and sales force to patients and physicians. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.

Corporate Governance

Champions Oncology, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.